Study Stopped
Lower prevalence than expected and the inclusion was difficult.
Children With Fever and Respiratory Symptoms at Out-of-hours Services in Norway
1 other identifier
interventional
401
0 countries
N/A
Brief Summary
Viral self-limiting infections in respiratory organs among children are common in primary care. Serious infections have low prevalence and are challenging to distinguish from self-limiting infections. Prescription of antibiotics in primary care is still high but stable since 2009 in Norway, and 90% of all antibiotics are prescribed in primary care. C-reactive protein (CRP) has been especially popular in Norway for point-of-care testing in primary care, but its role in ruling-out serious infections and the cut-off value for prescribing antibiotics has been discussed a lot. The aim of this study is to identify if pretesting with CRP of all children 0-6 year with fever or respiratory symptoms at Out-of-Hours Services will affect the prescription of antibiotics and the referral to hospital for children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2013
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 25, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedFirst Posted
Study publicly available on registry
July 14, 2015
CompletedDecember 3, 2015
December 1, 2015
2.4 years
June 25, 2015
December 2, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Antibiotic prescription rate
Number of participants prescribed antibiotics
24 hours
Secondary Outcomes (3)
Hospitalization rate
24 hours
Rate of side-effects of antibiotics
7 days
Duration of illness
7 days
Study Arms (2)
Pre-consultation CRP
ACTIVE COMPARATOREvery third child included get a CRP-test before the consultation and the doctor have the answer at start of consultation
CRP requested
NO INTERVENTIONNo intervention, the consultation with children as normal, the CRP is used at doctors request.
Interventions
Use of CRP test on all children with fever before the consultation (intervention) compared to where the doctor requests a CRP test (no intervention)
Eligibility Criteria
You may qualify if:
- Children 0-6 years with fever and/or respiratory symptoms
You may not qualify if:
- Children older than 6 years with other conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NORCE Norwegian Research Centre ASlead
- Haukeland University Hospitalcollaborator
Related Publications (8)
Brent AJ, Lakhanpaul M, Thompson M, Collier J, Ray S, Ninis N, Levin M, MacFaul R. Risk score to stratify children with suspected serious bacterial infection: observational cohort study. Arch Dis Child. 2011 Apr;96(4):361-7. doi: 10.1136/adc.2010.183111. Epub 2011 Jan 24.
PMID: 21266341BACKGROUNDVan den Bruel A, Thompson MJ, Haj-Hassan T, Stevens R, Moll H, Lakhanpaul M, Mant D. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review. BMJ. 2011 Jun 8;342:d3082. doi: 10.1136/bmj.d3082.
PMID: 21653621BACKGROUNDNordlie AL, Andersen BM. [Changes in antibiotic consumption among day-care children in Oslo]. Tidsskr Nor Laegeforen. 2007 Nov 15;127(22):2924-6. Norwegian.
PMID: 18026237BACKGROUNDRebnord IK, Sandvik H, Hunskaar S. Use of laboratory tests in out-of-hours services in Norway. Scand J Prim Health Care. 2012 Jun;30(2):76-80. doi: 10.3109/02813432.2012.684208.
PMID: 22643151RESULTMagnus MC, Vestrheim DF, Nystad W, Haberg SE, Stigum H, London SJ, Bergsaker MA, Caugant DA, Aaberge IS, Nafstad P. Decline in early childhood respiratory tract infections in the Norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccination. Pediatr Infect Dis J. 2012 Sep;31(9):951-5. doi: 10.1097/INF.0b013e31825d2f76.
PMID: 22627867RESULTAlvsaker LKT, Stensen MF, Mjelle AB, Hunskaar S, Rebnord IK. Outcomes of antibiotic treatment for respiratory infections in children an observational study in primary care. Scand J Prim Health Care. 2024 Jun;42(2):237-245. doi: 10.1080/02813432.2024.2305929. Epub 2024 Jan 24.
PMID: 38265029DERIVEDRebnord IK, Sandvik H, Mjelle AB, Hunskaar S. Factors predicting antibiotic prescription and referral to hospital for children with respiratory symptoms: secondary analysis of a randomised controlled study at out-of-hours services in primary care. BMJ Open. 2017 Jan 17;7(1):e012992. doi: 10.1136/bmjopen-2016-012992.
PMID: 28096254DERIVEDRebnord IK, Sandvik H, Mjelle AB, Hunskaar S. Out-of-hours antibiotic prescription after screening with C reactive protein: a randomised controlled study. BMJ Open. 2016 May 12;6(5):e011231. doi: 10.1136/bmjopen-2016-011231.
PMID: 27173814DERIVED
Related Links
Study Officials
- STUDY DIRECTOR
Steinar Hunskår, Prof. dr.med
NORCE Norwegian Research Centre AS
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 25, 2015
First Posted
July 14, 2015
Study Start
January 1, 2013
Primary Completion
June 1, 2015
Study Completion
July 1, 2015
Last Updated
December 3, 2015
Record last verified: 2015-12